A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.
about
A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signalsA novel variant of human Grb7 is associated with invasive esophageal carcinomaAssociation of insulin receptor substrate proteins with Bcl-2 and their effects on its phosphorylation and antiapoptotic functionBiologic significance of angiopoietin-2 expression in human hepatocellular carcinomaOverexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liverOverexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosisImmunological approach to hepatocellular carcinoma.IRS1 regulation by Wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype.Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma.Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma.Type 1 Insulin-Like Growth Factor Receptor/Insulin Receptor Substrate 1 Signaling Confers Pathogenic Activity on Breast Tumor Cells Lacking REST.Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapyInsulin-Like Growth Factor 1 Receptor-Dependent Pathway Drives Epicardial Adipose Tissue Formation After Myocardial Injury.Activation of signal transduction pathways during hepatic oncogenesisThalidomide induces limb anomalies by PTEN stabilization, Akt suppression, and stimulation of caspase-dependent cell deathPotential roles of tumor suppressor genes and microsatellite instability in hepatocellular carcinogenesis in southern African blacks.Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only.Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cellsReactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.Expression and function of the insulin receptor substrate proteins in cancerInsulin receptor substrate-1 associates with small nucleolar RNA which contributes to ribosome biogenesis.miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.An insulin signaling feedback loop regulates pancreas progenitor cell differentiation during islet development and regeneration.Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells.Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma.Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis.
P2860
Q24324809-93110E34-FAFE-428C-A018-03F93DD5F54DQ24328874-4064384E-7971-480E-BFCF-5FE761BBCA83Q24548364-BD800364-866F-4142-A833-9A89CCBB8E8BQ24563486-2AEBBCCD-A2E4-43AB-B74A-F639F520BC6BQ28246572-3EEA5ECE-55B2-4FA7-831F-1626150EC389Q28261957-AE0FEDD8-02C7-4093-9F46-CE6280B9896AQ32147095-F7D76B25-0525-4F3A-B9B1-6D680297A347Q33581982-B93EC114-6224-47FF-902D-EDC3FB4F325EQ35282099-E7513982-5703-41C8-9FD3-477AD4B4CC7FQ35594730-0744EE96-D35B-4DD4-85A3-A17BBB8BBFC7Q35917441-0B47C9E8-4002-4978-8406-2478FC9CDD30Q36109818-DDE17063-0B03-4559-B414-5876577BE626Q36179651-699CA1E0-8E06-4748-AF5E-272ADD58226DQ36386273-25324D7D-E128-479A-93EC-953BABD39EF9Q36421389-9417A066-A4E4-48F6-B63B-5011A228BB1BQ36492146-8F18211D-1F2E-483A-9CE0-E72037DE8656Q36972045-0276D543-1F60-400C-96ED-82C72C303BC9Q36996036-EC1F1A5B-BEA2-4489-97F5-8F94E0522EAFQ37113552-5AAD6FAF-8A40-449A-B2EB-29E0A9384E32Q37257933-3A7E35D3-F72A-44EE-AE29-812E28592420Q37615800-16E10CAE-A996-4BB4-B884-0C75BE4DEA3EQ39227955-E2952E61-F22D-4651-BD98-F5C5B951AA0DQ39460470-171DD8AA-9FC1-43F2-9CFF-23261CAA8E77Q40220580-9FBB7991-DE69-43D6-9EE8-775E221346C1Q40618771-C0EBB060-A3EC-404C-BE6E-06684271D339Q43933938-AFCED70C-A34B-4F76-988E-6B9C030DB262Q54610409-88A9BE83-7329-467E-BABA-B4CAEE5E25EF
P2860
A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
A carboxy-terminal truncated i ...... carcinoma malignant phenotype.
@en
A carboxy-terminal truncated i ...... carcinoma malignant phenotype.
@nl
type
label
A carboxy-terminal truncated i ...... carcinoma malignant phenotype.
@en
A carboxy-terminal truncated i ...... carcinoma malignant phenotype.
@nl
prefLabel
A carboxy-terminal truncated i ...... carcinoma malignant phenotype.
@en
A carboxy-terminal truncated i ...... carcinoma malignant phenotype.
@nl
P2860
P356
P1476
A carboxy-terminal truncated i ...... carcinoma malignant phenotype.
@en
P2093
P2860
P304
P356
10.1172/JCI119016
P407
P577
1996-11-01T00:00:00Z